{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T01:40:08Z","timestamp":1758937208181,"version":"3.44.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.leukres.2022.106859","type":"journal-article","created":{"date-parts":[[2022,5,11]],"date-time":"2022-05-11T12:13:27Z","timestamp":1652271207000},"page":"106859","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["PTPN11 mutations in adult acute myeloid leukaemia: Prevalence and clinical implications in the context of NPM1 mutation"],"prefix":"10.1016","volume":"118","author":[{"given":"Jie","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Qin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Biao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiying","family":"Hua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhuxia","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongying","family":"Chao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuzhang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"23","key":"10.1016\/j.leukres.2022.106859_bib1","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa1516192","article-title":"Genomic classification and prognosis in acute myeloid leukemia","volume":"374","author":"Papaemmanuil","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.leukres.2022.106859_bib2","doi-asserted-by":"crossref","first-page":"4011","DOI":"10.1182\/blood-2005-08-3167","article-title":"Prevalence and prognostic impact of NPM1 mutations in 1485 adult patients with acute myeloid leukemia (AML)","volume":"107","author":"Thiede","year":"2006","journal-title":"Blood"},{"issue":"20","key":"10.1016\/j.leukres.2022.106859_bib3","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2022.106859_bib4","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.leukres.2017.01.027","article-title":"Coexisting and cooperating mutations in NPM1-mutated acute myeloid leukemia","volume":"56","author":"Patel","year":"2017","journal-title":"Leuk. Res."},{"issue":"4","key":"10.1016\/j.leukres.2022.106859_bib5","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/ijlh.12802","article-title":"Mutation profile and associated clinical features in Chinese patients with cytogenetically normal acute myeloid leukemia","volume":"40","author":"Wang","year":"2018","journal-title":"Int. J. Lab. Hematol."},{"issue":"2","key":"10.1016\/j.leukres.2022.106859_bib6","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.3324\/haematol.2015.133819","article-title":"Molecular subtypes of NPM1 mutations have different clinical profiles, specific patterns of accompanying molecular mutations and varying outcomes in intermediate risk acute myeloid leukemia","volume":"101","author":"Alpermann","year":"2016","journal-title":"Haematologica"},{"issue":"12","key":"10.1016\/j.leukres.2022.106859_bib7","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1056\/NEJMoa1112304","article-title":"Prognostic relevance of integrated genetic profiling in acute myeloid leukemia","volume":"366","author":"Patel","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.leukres.2022.106859_bib8","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1002\/ajh.25517","article-title":"The combination of NPM1, DNMT3A and IDH1\/2 mutations leads to inferior overall survival in AML","volume":"94","author":"Dunlap","year":"2019","journal-title":"Am. J. Hematol."},{"issue":"5","key":"10.1016\/j.leukres.2022.106859_bib9","doi-asserted-by":"crossref","first-page":"e196","DOI":"10.3324\/haematol.2014.115576","article-title":"Impact of additional genetic alterations on the outcome of patients with NPM1-mutated cytogenetically normal acute myeloid leukemia","volume":"100","author":"Peterlin","year":"2015","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.leukres.2022.106859_bib10","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/leu.2015.288","article-title":"Complex molecular genetic abnormalities involving three or more genetic mutations are important prognostic factors for acute myeloid leukemia","volume":"30","author":"Wakita","year":"2016","journal-title":"Leukemia"},{"issue":"11","key":"10.1016\/j.leukres.2022.106859_bib11","doi-asserted-by":"crossref","first-page":"9498","DOI":"10.1074\/jbc.M110547200","article-title":"Regulation of the Mitogen-activated Protein Kinase Signaling Pathway by SHP2","volume":"277","author":"Cunnick","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"15","key":"10.1016\/j.leukres.2022.106859_bib12","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1021\/acs.biochem.5b01287","article-title":"Structural and functional consequences of three cancer-associated mutations of the oncogenic phosphatase SHP2","volume":"55","author":"Larochelle","year":"2016","journal-title":"Biochemistry"},{"issue":"3","key":"10.1016\/j.leukres.2022.106859_bib13","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1182\/blood-2006-07-028829","article-title":"PTPN11 is the first identified proto-oncogene that encodes a tyrosine phosphatase","volume":"109","author":"Chan","year":"2007","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.leukres.2022.106859_bib14","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1507\/endocrj.EJ18-0564","article-title":"Genotype-phenotype correlation analysis in Japanese patients with Noonan syndrome","volume":"66","author":"Yasuko","year":"2019","journal-title":"Endocr. J."},{"issue":"6","key":"10.1016\/j.leukres.2022.106859_bib15","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1111\/j.1365-2141.2010.08525.x","article-title":"Recent advances in the pathogenesis and treatment of juvenile myelomonocytic leukaemia","volume":"152","author":"Loh","year":"2011","journal-title":"Br. J. Haematol."},{"issue":"9","key":"10.1016\/j.leukres.2022.106859_bib16","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.28368","article-title":"Juvenile myelomonocytic leukaemia presentation after preceding juvenile xanthogranuloma harbouring an identical somatic PTPN11 mutation","volume":"67","author":"Batai","year":"2020","journal-title":"Pedia Blood Cancer"},{"issue":"2","key":"10.1016\/j.leukres.2022.106859_bib17","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/ng1156","article-title":"Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia","volume":"34","author":"Tartaglia","year":"2003","journal-title":"Nat. Genet"},{"issue":"6","key":"10.1016\/j.leukres.2022.106859_bib18","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/j.1365-2141.2004.04862.x","article-title":"Mutations in PTPN11 are uncommon in adult myelodysplastic syndromes and acute myeloid leukaemi","volume":"124","author":"Johan","year":"2004","journal-title":"Br. J. Haematol."},{"issue":"3","key":"10.1016\/j.leukres.2022.106859_bib19","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/s41375-020-0920-z","article-title":"The Clinical impact of PTPN11 mutations in adults with acute myeloid leukemia","volume":"35","author":"Alfayez","year":"2021","journal-title":"Leukemia"},{"issue":"5","key":"10.1016\/j.leukres.2022.106859_bib20","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1038\/sj.leu.2405005","article-title":"Characterization of acute myeloid leukemia with PTPN11 mutation: the mutation is closely associated with NPM1 mutation but inversely related to FLT3\/ITD","volume":"22","author":"Hou","year":"2008","journal-title":"Leukemia"},{"issue":"17","key":"10.1016\/j.leukres.2022.106859_bib21","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1182\/bloodadvances.2021004631","article-title":"Impact of PTPN11 mutations on clinical outcome analyzed in 1529 patients with acute myeloid leukemia","volume":"5","author":"Stasik","year":"2021","journal-title":"Blood Adv."},{"issue":"4","key":"10.1016\/j.leukres.2022.106859_bib22","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/leu.2013.273","article-title":"The role of different genetic subtypes of CEBPA mutated AML","volume":"28","author":"Fasan","year":"2014","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.leukres.2022.106859_bib23","doi-asserted-by":"crossref","first-page":"49","DOI":"10.4274\/tjh.2017.0095","article-title":"NPM1 mutation analysis in acute myeloid leukemia: comparison of three techniques -sanger sequencing, pyrosequencing, and real-time polymerase chain reaction","volume":"35","author":"Kumar","year":"2018","journal-title":"Turk. J. Haematol."},{"issue":"12","key":"10.1016\/j.leukres.2022.106859_bib24","doi-asserted-by":"crossref","first-page":"4326","DOI":"10.1182\/blood.V99.12.4326","article-title":"Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis","volume":"99","author":"Thiede","year":"2002","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.leukres.2022.106859_bib25","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/ijlh.13030","article-title":"Cytogenetics and associated mutation profile in patients with acute monocytic leukemia","volume":"41","author":"Xing","year":"2019","journal-title":"Int J. Lab Hematol."},{"key":"10.1016\/j.leukres.2022.106859_bib26","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0065-230X(10)06002-1","article-title":"The tyrosine phosphatase Shp2 in development and cancer","volume":"106","author":"Grossmann","year":"2010","journal-title":"Adv. Cancer Res"},{"issue":"4","key":"10.1016\/j.leukres.2022.106859_bib27","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0092-8674(00)80938-1","article-title":"Crystal structure of the tyrosine phosphatase SHP-2","volume":"92","author":"Hof","year":"1998","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.leukres.2022.106859_bib28","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1111\/j.1349-7006.2009.01257.x","article-title":"Protein tyrosine phosphatase SHP-2: a proto-oncogene product that promotes Ras activation","volume":"100","author":"Matozaki","year":"2009","journal-title":"Cancer Sci."},{"issue":"1","key":"10.1016\/j.leukres.2022.106859_bib29","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s12881-020-0986-5","article-title":"Molecular and clinical studies in 107 Noonan syndrome affected individuals with PTPN11 mutations","volume":"21","author":"Narayanan","year":"2020","journal-title":"BMC Med Genet"},{"issue":"7","key":"10.1016\/j.leukres.2022.106859_bib30","doi-asserted-by":"crossref","first-page":"3359","DOI":"10.1210\/jc.2003-032091","article-title":"Protein-tyrosine phosphatase, nonreceptor type 11 mutation analysis and clinical assessment in 45 patients with noonan syndrome","volume":"89","author":"Athota","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.leukres.2022.106859_bib31","first-page":"412","article-title":"Low frequency of exon 3 PTPN11 mutations in adult de novo acute myeloid leukemia. Analysis of a consecutive series of 173 patients","volume":"90","author":"Yoshida","year":"2005","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2022.106859_bib32","first-page":"425","article-title":"Low frequency of exon 3 PTPN11 mutations in adult de novo acute myeloid leukemia. Analysis of a consecutive series of 173 patients","volume":"90","author":"Nomdedeu","year":"2005","journal-title":"Haematologica"},{"issue":"6","key":"10.1016\/j.leukres.2022.106859_bib33","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1182\/blood-2003-09-3287","article-title":"Mutations in PTPN11 implicate the SHP-2 phosphatase in leukemogenesis","volume":"103","author":"Loh","year":"2004","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.leukres.2022.106859_bib34","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/leu.2009.200","article-title":"PTPN11 mutations in childhood acute lymphoblastic leukemia occur as a secondary event associated with high hyperdiploidy","volume":"24","author":"Molteni","year":"2010","journal-title":"Leukemia"},{"issue":"5","key":"10.1016\/j.leukres.2022.106859_bib35","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/j.1365-2141.2005.05685.x","article-title":"Differences in the prevalence of PTPN11 mutations in FAB M5 paediatric acute myeloid leukaemia","volume":"130","author":"Goemans","year":"2005","journal-title":"Br. J. Haematol."},{"issue":"11","key":"10.1016\/j.leukres.2022.106859_bib36","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1038\/sj.leu.2403492","article-title":"PTPN11 mutations in pediatric patients with acute myeloid leukemia: results from the Children\u2019s Cancer Group","volume":"18","author":"Loh","year":"2004","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.leukres.2022.106859_bib37","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/s41375-020-01083-3","article-title":"PTPN11 mutations are associated with poor outcomes across myeloid malignancies","volume":"35","author":"Swoboda","year":"2021","journal-title":"Leukemia"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212622000856?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212622000856?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T01:01:56Z","timestamp":1758934916000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212622000856"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":37,"alternative-id":["S0145212622000856"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2022.106859","relation":{},"ISSN":["0145-2126"],"issn-type":[{"type":"print","value":"0145-2126"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PTPN11 mutations in adult acute myeloid leukaemia: Prevalence and clinical implications in the context of NPM1 mutation","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2022.106859","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106859"}}